DK161331C - Analogifremgangsmaade til fremstilling af 7beta-substitueret malonamido-1-oxadethia-7alfa-methoxy-3-(1-methyltetrazol-5-yl)thiomethyl-cephalosporiner - Google Patents

Analogifremgangsmaade til fremstilling af 7beta-substitueret malonamido-1-oxadethia-7alfa-methoxy-3-(1-methyltetrazol-5-yl)thiomethyl-cephalosporiner

Info

Publication number
DK161331C
DK161331C DK131277A DK131277A DK161331C DK 161331 C DK161331 C DK 161331C DK 131277 A DK131277 A DK 131277A DK 131277 A DK131277 A DK 131277A DK 161331 C DK161331 C DK 161331C
Authority
DK
Denmark
Prior art keywords
7alfa
malonamido
oxadethia
cephalosporines
7beta
Prior art date
Application number
DK131277A
Other languages
Danish (da)
English (en)
Other versions
DK161331B (da
DK131277A (da
Inventor
Masayuki Narisada
Wataru Nagata
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3340176A external-priority patent/JPS52122386A/ja
Priority claimed from JP5029576A external-priority patent/JPS52133997A/ja
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of DK131277A publication Critical patent/DK131277A/da
Publication of DK161331B publication Critical patent/DK161331B/da
Application granted granted Critical
Publication of DK161331C publication Critical patent/DK161331C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D505/00Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK131277A 1976-03-25 1977-03-24 Analogifremgangsmaade til fremstilling af 7beta-substitueret malonamido-1-oxadethia-7alfa-methoxy-3-(1-methyltetrazol-5-yl)thiomethyl-cephalosporiner DK161331C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP3340176 1976-03-25
JP3340176A JPS52122386A (en) 1976-03-25 1976-03-25 Cephalosporin analogous compounds as antibacterials
JP5029576A JPS52133997A (en) 1976-04-30 1976-04-30 Cephalosporin antibiotics
JP5029576 1976-04-30

Publications (3)

Publication Number Publication Date
DK131277A DK131277A (da) 1977-09-26
DK161331B DK161331B (da) 1991-06-24
DK161331C true DK161331C (da) 1991-12-09

Family

ID=26372085

Family Applications (1)

Application Number Title Priority Date Filing Date
DK131277A DK161331C (da) 1976-03-25 1977-03-24 Analogifremgangsmaade til fremstilling af 7beta-substitueret malonamido-1-oxadethia-7alfa-methoxy-3-(1-methyltetrazol-5-yl)thiomethyl-cephalosporiner

Country Status (19)

Country Link
AR (1) AR224606A1 (fr)
BG (1) BG31074A3 (fr)
CY (1) CY1158A (fr)
DD (1) DD129792A5 (fr)
DE (1) DE2713370C2 (fr)
DK (1) DK161331C (fr)
ES (5) ES457174A1 (fr)
GR (1) GR61146B (fr)
HK (1) HK46882A (fr)
HU (1) HU172720B (fr)
IE (1) IE44794B1 (fr)
IL (1) IL51743A (fr)
MX (1) MX4348E (fr)
NO (2) NO158505C (fr)
NZ (1) NZ183687A (fr)
PT (1) PT66346B (fr)
RO (2) RO71742A (fr)
SE (1) SE443143B (fr)
YU (2) YU44039B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1557552A (en) * 1977-02-15 1979-12-12 Shionogi & Co 1 oxadethiacepham compounds
US4252953A (en) * 1979-05-01 1981-02-24 Eli Lilly And Company Antibiotic crystalline epimer
JPS60123490A (ja) * 1983-12-07 1985-07-02 Shionogi & Co Ltd マロニルオキサセフェムカルボン酸誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL178005C (nl) * 1972-11-06 1986-01-02 Merck & Co Inc Werkwijze voor het bereiden van een farmaceutisch preparaat met antibacteriele werking, alsmede werkwijze ter bereiding van een cefalosporine-antibioticum.
US3962232A (en) * 1973-11-05 1976-06-08 Eli Lilly And Company 7-methoxycephalosporins
GB1449420A (en) * 1973-11-26 1976-09-15 Sankyo Co 7alpha-methoxycephalosporing derivatives

Also Published As

Publication number Publication date
DE2713370A1 (de) 1977-09-29
HU172720B (hu) 1978-11-28
HK46882A (en) 1982-11-19
DE2713370C2 (de) 1994-04-21
ES469286A1 (es) 1979-09-16
YU44038B (en) 1990-02-28
NZ183687A (en) 1979-01-11
YU173883A (en) 1983-12-31
YU173783A (en) 1983-12-31
DD129792A5 (de) 1978-02-08
RO78228A (fr) 1982-02-01
SE7703325L (sv) 1977-09-26
CY1158A (en) 1983-01-28
SE443143B (sv) 1986-02-17
DK161331B (da) 1991-06-24
NO862107L (no) 1977-09-27
IE44794L (en) 1977-09-25
ES469287A1 (es) 1979-09-16
GR61146B (en) 1978-09-27
NO158505B (no) 1988-06-13
MX4348E (es) 1982-04-05
PT66346B (en) 1978-08-16
YU44039B (en) 1990-02-28
AR224606A1 (es) 1981-12-30
RO71742A (fr) 1982-02-26
PT66346A (en) 1977-04-01
ES457174A1 (es) 1978-08-16
NO771023L (no) 1977-09-27
DK131277A (da) 1977-09-26
ES469284A1 (es) 1978-11-16
ES469285A1 (es) 1979-09-16
IL51743A (en) 1980-10-26
IE44794B1 (en) 1982-04-07
BG31074A3 (en) 1981-10-15
NO158505C (no) 1988-09-21

Similar Documents

Publication Publication Date Title
DK149062C (da) Analogifremgangsmaade til fremstilling af cefuroximestere
DK377A (da) Fremgangsmade til fremstilling af n-phosphonomethyl-glycin
DK150903C (da) Analogifremgangsmaade til fremstilling af benzisoselenazoloner
DK46777A (da) Fremgangsmade til fremstilling af meta-aryloxybenzaldehyder
DK244577A (da) Fremgangsmade til fremstilling af hydantoinderivater
DK148059C (da) Analogifremgangsmaade til fremstilling af anthracyclinglycosidforbindelser
DK276177A (da) Fremgangsmade til fremstilling af gammapyron-forbindelser
DK577977A (da) Fremgangsmaade til fremstilling af alfa-l-aspartyl-l-phenylalanin-methyler
DK339677A (da) Fremgangsmade til fremstilling af 2-benzylpyrrolidiner
DK584777A (da) Fremgangsmaade til fremstilling af sterolinforbindelser
DK144377A (da) Fremgangsmade til fremstilling af acylcyanider
DK587077A (da) Fremgangsmaade til fremstilling af estere
DK216977A (da) Fremgangsmade til fremstilling af imidazobenzoxaziner
DK144277A (da) Fremgangsmade til fremstilling af acylcyanider
DK73977A (da) Fremgangsmade til fremstilling af d-homosteroider
DK161331C (da) Analogifremgangsmaade til fremstilling af 7beta-substitueret malonamido-1-oxadethia-7alfa-methoxy-3-(1-methyltetrazol-5-yl)thiomethyl-cephalosporiner
DK73277A (da) Fremgangsmaade til fremstilling af sulfonylbenzimidazoler
DK208677A (da) Fremgangsmade til fremstilling af maphthylforbindelser
DK148684C (da) Analogifremgangsmaade til fremstilling af aryl-alkylaminer
DK123177A (da) Fremgangsmade til fremstilling af 7-alkoxy-3-chlormethyl-3-cephem-forbindelser
DK538977A (da) Fremgangsmaade til fremstilling af 17alfa-hydroxy-21-acetoxy-progesteron
DK196577A (da) Fremgangsmade til fremstilling af kolecystokinin-pankreozymin-oktapeptidamidsulfatester
DK147596C (da) Analogifremgangsmaade til fremstilling af 7-alkoxymethylpuriner
DK155008C (da) Fremgangsmaade til fremstilling af 3-methylencepham-forbindelser
DK301377A (da) Fremgangsmade til fremstilling af cishexahydrodibenzopyranoner

Legal Events

Date Code Title Description
PBP Patent lapsed